Online Exclusives

Online Exclusives

FDA Orders Allergan to Recall Textured Breast Implants Over Cancer Risk

The U.S. Food and Drug Administration (FDA) has requested that Allergan recall its BIOCELL textured breast implants due to a risk of breast implant-associated...

U.K. Denying Benefit to Patients With Sickle Cell Disease

The U.K. government has been withholding personal independence payments (PIPs) from patients with sickle cell disease because the condition does not fit government criteria...

Genetic Testing Companies Are Partnering With Drug Companies to Develop New Medicines

Last year, the consumer genetic testing company 23andMe joined forces with drug manufacturer GlaxoSmithKline (GSK) to detect potential drug targets. Now, that relationship has...

NIH Releases New Requirements for Fetal Tissue Research Funding

The National Institute of Health’s (NIH’s) new grant application guidance for researchers planning to use fetal tissue will require that all applicants adhere to...

FDA Requires Boxed Warning for Tofacitinib

The U.S. Food and Drug Administration (FDA) has issued a Safety Announcement requiring a boxed warning for the Janus kinase (JAK) inhibitor tofacitinib, indicating...

Bluebird Bio Wins European Approval for Beta Thalassemia Gene Therapy

Bluebird Bio’s one-time gene therapy, Zynteglo, has been cleared by E.U. regulators for the treatment of beta thalassemia in patients aged 12 and older....

Opioid Manufacturer Insys Therapeutics Files for Bankruptcy

Insys Therapeutics filed for Chapter 11 bankruptcy protection on June 10, just days after reaching a $225 million settlement with the U.S. Department of...

FDA Launches Call Center for Compassionate-Use Requests

The FDA has launched a call center to field doctors’ requests for access to experimental cancer drugs for individual patients who have run out...

Polatuzumab Vedotin-piiq Receives FDA Approval for DLBCL

The FDA has approved the CD79b-directed antibody drug conjugate polatuzumab vedotin-piiq, in combination with bendamustine and rituximab (BR), to treat adults with relapsed or...

Canada Warns Exporting Drugs Could Cause Drug Shortage

The Trump administration has proposed importing prescription drugs from other countries to help drive down the high costs of medications in the U.S., but...
Advertisement

Current Issue

August 2019, Volume 5, Issue 10

August 2019, Volume 5, Issue 10

This issue features a debate about gun control as a health care issue, a look at blood services in Israel and Palestine, and more.